Adavale Resources keeping up the nickel exploration pace at Kabanga Jirani
Adavale Resources plans to carry out a deep penetrating ground EM survey and potential follow-up drill testing at HEM 4 A sixth diamond hole at [more…]
ASX Health Stocks: Mesoblast rockets 20pc after being granted Rare Pediatric Disease Designation by FDA
Mesoblast granted Rare Pediatric Disease (RPD) Designation by FDA Visioneering Technologies releases its full 1-year results on children with myopia Mesoblast blasts away 20pc [more…]
The Secret Broker: Then I saw her shorts… now I want to leave her!
After 35 years of stockbroking for some of the biggest houses and investors in Australia and the UK, the Secret Broker is regaling Stockhead readers [more…]
Top 10 at 10: FDA wins on a Friday
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Market Highlights: Tech rally on Nasdaq, commodities bounce back, and 5 ASX small caps to watch today
ASX to bounce back strongly after a tech rally on Wall Street Commodity prices bounced back Goldman says small caps will play catch-up this year [more…]
Basin Energy starts exploring for potential repeats of Cameco’s Millennium 104.8Mlb deposit in Canada’s Athabasca Basin
A ground electromagnetic survey has commenced at North Millennium and Marshall, as Basin Energy searches for repeats of Cameco’s Millennium deposit BSN says there is [more…]
GOT GAS: Santos’ Barossa pipeline victory could lift certainty for gas players
Unless you have been living under the rock or swanning away on a holiday, you would know that Santos has been given the go ahead [more…]
Emission Control: QLD doubles down on batteries to leverage rooftop solar dominance
QLD Government invests $179m into the state’s next stage of local network connected batteries QLD has highest rate of rooftop solar installations in Australia (one [more…]
The next Neuren? These ASX biotech stocks have pending FDA catalysts in 2024
An FDA approval is the holy grail for most biotech stocks Neuren, Compumedics and Cyclopharm received FDA approvals in 2023 We take a look at [more…]
The launch of bullion-backed ETFs shot gold into the stratosphere. Could SEC approval do the same for Bitcoin?
Money piles into Global X spot Bitcoin ETF after US regulators approve spot bitcoin ETF The SEC approval of Bitcoin ETFs is being compared to [more…]
